The American College of Radiology has “significant concerns” about the federal government’s proposed physician payment schedule for 2020 and is worried it could have a “devastating impact” on medical imaging.

As House Democrats launch a formal impeachment inquiry against President Trump, bipartisan healthcare efforts focused on lowering drug prices and healthcare costs are at risk of falling by the wayside, The Hill reported.

Frequent and persistent hot flashes during menopause can majorly raise women’s risk of clinical CVD events in the following 20 years, researchers reported at the 30th Annual Meeting of the North American Menopause Society.

The Radiological Society of North America (RSNA) has published their first issue of Radiology: Imaging Cancer, a new online journal dedicated to the latest in cancer imaging.

Medtronic announced Sept. 27 that it had received FDA approval to launch an early feasibility study for its Intrepid TMVR system using a minimally invasive transfemoral access approach.

More major companies continue to jump on the problem of healthcare affordability, with the latest pilot launched by Sam’s Club, a membership-only warehouse retailer owned by Walmart.

Tests commissioned by NBC News have revealed that vitamin E—the suspected culprit behind some 800-plus reported cases of vaping-related lung illness—is present in many THC cartridges sold on the black market, alongside other toxicities like pesticides and myclobutanil.

“Knowing that the cancer yield of screening US is similar after DBT versus DM may help inform clinical practice, because questions abound about whether DBT is sufficient screening for women with dense breast tissue," wrote authors of a new study published in the American Journal of Roentgenology.

Engineers and roboticists in Europe have invented an artificial skin that can provide wearers with haptic feedback—replicating the human sense of touch—for potential applications in various fields, including medical rehabilitation and physical therapy. 

A shortened, three-month course of dual antiplatelet therapy might be a safer bet than 12-month treatment for patients at a high risk of bleeding after PCI and implantation of a drug-eluting stent.